EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/06/2026
Back to search
Official data from USPTO
RESTASIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
07/09/2026
Trademark type
Word
Nice classes
5
Filing date
01/03/2001
Registration date
07/15/2003
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/14/2023
Last transaction
07/09/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/29/1997
First use in commerce
04/01/2003
Drawing code
1
Owner type
03
Owner location
North Chicago, IL, US
Examiner
GARTNER, JOHN M
Law office
N10
Current location
TMO LAW OFFICE 119
Holders and representatives
Holders
Allergan, Inc.
Allergan, Inc.
Representatives
Maryam S. Arastu AbbVie Inc.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Topical ophthalmic pharmaceutical products for the treatment of dryness of the eye
Publications
History of USPTO decisions and trademark events.
36 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/06/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/06/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/06/2026
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02/14/2023
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
02/14/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02/14/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/13/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
07/27/2022
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/15/2022
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02/23/2013
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
02/22/2013
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02/22/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/22/2013
E89R
TEAS SECTION 8 & 9 RECEIVED
02/06/2013
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/06/2013
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/28/2008
PLGL
ASSIGNED TO PARALEGAL
08/19/2008
E815
TEAS SECTION 8 & 15 RECEIVED
08/12/2008
CFIT
CASE FILE IN TICRS
05/27/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
07/15/2003
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/06/2003
DOCK
ASSIGNED TO EXAMINER
05/05/2003
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/01/2003
IUAF
USE AMENDMENT FILED
04/15/2003
EISU
TEAS STATEMENT OF USE RECEIVED
04/15/2003
EX2G
SOU EXTENSION 2 GRANTED
12/03/2002
EXT2
SOU EXTENSION 2 FILED
09/19/2002
EEXT
SOU TEAS EXTENSION RECEIVED
09/19/2002
EX1G
SOU EXTENSION 1 GRANTED
02/28/2002
EXT1
SOU EXTENSION 1 FILED
02/14/2002
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
11/13/2001
PUBO
PUBLISHED FOR OPPOSITION
08/21/2001
NPUB
NOTICE OF PUBLICATION
08/01/2001
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/02/2001
DOCK
ASSIGNED TO EXAMINER
05/24/2001
Continuous trademark protection
Get notified about every new filing that threatens RESTASIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.